Steven M. Scott, MD, HS’74-78, has been named the recipient of the 2025 Distinguished Service Award by the Duke Medical Alumni Association in recognition of his selfless service, steadfast passion for Duke, and transformative contributions to education, college athletics and health care institutions.

Pamela S. Douglas, MD, has been named a recipient of a 2025 Distinguished Faculty Award by the Duke Medical Alumni Association in recognition of her pioneering contributions to the field of cardiology.

Lori J. Pierce, MD’85, has been named the recipient of a Distinguished Alumni Award by the Duke Medical Alumni Association in recognition of her pioneering work in advancing breast cancer treatment and her leadership in education and training.

Joseph Heitman, MD, PhD, has been named the recipient of a 2025 Distinguished Faculty Award by the Duke Medical Alumni Association in recognition of his significant contributions to biomedical science, education, clinical impact, and leadership.

Cameron R. Wolfe, MD, HS’07-’08, professor of medicine in the Division of Infectious Diseases at Duke University, has been named a recipient of a Duke Medical Alumni Association 2025 Distinguished Faculty Award in recognition of his sustained contributions to clinical care, research, education, and institutional leadership.

Amy P. Murtha, MD, HS’92-’98, has been honored with a 2025 Distinguished Alumni Award by the Duke Medical Alumni Association for her sustained commitment to improving maternal-fetal health and advancing academic medicine.

School of Medicine researchers have developed two pioneering studies that offer a new approach to ensuring that AI systems used in clinical settings meet the highest standards of quality and accountability.

The new facility will add hospital services to the existing Duke Health Cary location, including an emergency room, surgical services, imaging, cancer treatments, and other care.

Ashley Moseman, PhD, assistant professor of integrative immunobiology, has been named a 2025 recipient of the highly competitive Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award.

Researchers at Duke University are developing a new, non-addictive way to treat chronic pain using a natural compound in the body called adenosine. Their early results show this approach could be more effective than current medications and offer a safer alternative to opioids, with fewer side effects and no risk of addiction.